The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model
- 2018-10-11
- Journal of the American College of Nutrition 38(3)
- Ghazaleh Mohammadi
- L. Dargahi
- A. Peymani
- Y. Mirzanejad
- S. Alizadeh
- T. Naserpour
- Marjan Nassiri-Asl
- PubMed: 30307792
- DOI: 10.1080/07315724.2018.1487346
Abstract
Objective: The role of gut microbiota in the pathogenesis of several neurodegenerative disorders, including Alzheimer's disease (AD), via the gut-brain axis has recently been demonstrated; hence, modification of the intestinal microbiota composition by probiotic biotherapy could be a therapeutic target for these conditions. The aim of this study was to assess the effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on inflammatory and memory processes in lipopolysaccharide (LPS)-induced rats, one of the animal models used in peripherally induced neuroinflammation and neurodegeneration.
Methods: Rats were randomly divided into four groups (Control, LPS, Probiotic + LPS, and Probiotic). All experimental groups were orally administrated maltodextrin (placebo) or probiotic (109 CFU/ml/rat) for 14 consecutive days and then were injected with saline or LPS (1 mg/kg, intraperitoneally [i.p.], single dose) 20 hours later. Memory retention ability and systemic and neuroinflammatory markers were assessed 4 hours after the injections.
Results: Systemic exposure to LPS resulted in significant elevation of both the circulating and hippocampal levels of proinflammatory cytokines, which decreased remarkably following probiotic pretreatment. Oral bacteriotherapy with a combination of L. helveticus R0052 and B. longum R0175 also attenuated the decremental effect of LPS on memory through brain-derived neurotrophic factor (BDNF) expression at the molecular level; however, this effect was not significant in the passive avoidance test at the behavioral level.
Conclusions: These results suggest that the management of gut microbiota with this probiotic formulation could be a promising intervention to improve neuroinflammation-associated disorders such as AD.
Keywords: Alzheimer’s disease; Probiotic; lipopolysaccharide; memory; neuroinflammation.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus helveticus R0052 | Enhanced Brain-Derived Neurotrophic Factor Levels | Beneficial | Moderate |
Lactobacillus helveticus R0052 | No Significant Improvement in Memory Retention | Neutral | Small |
Lactobacillus helveticus R0052 | Reduced Pro-Inflammatory Cytokines | Beneficial | Large |